Management of Apixaban for Ascitic Tapping and Lumbar Puncture

General Guidelines

The American Heart Association/American College of Cardiology recommends continuing apixaban without interruption for ascitic tapping, as it is a minimal bleeding risk procedure where local hemostasis can be readily achieved 1
The American Heart Association/American College of Cardiology guidelines state that lumbar puncture is a high bleeding risk procedure requiring complete hemostasis, as spinal/epidural bleeding can cause permanent neurological damage 1, 3

Paracentesis is classified as a minimal bleeding risk procedure with a 30-day major bleeding risk of 0%, similar to minor dermatological procedures 1
The American Heart Association/American College of Cardiology explicitly states it is safe to perform procedures with minimal bleeding risk without interrupting oral anticoagulation 1
Continue apixaban at regular dosing throughout the procedure, with no interruption of anticoagulation required 1

Stop apixaban 48 hours before lumbar puncture in patients with normal renal function, and extend to 72-96 hours in those with creatinine clearance <30 mL/min 1
The American College of Cardiology warns that procedures requiring complete hemostasis, such as spinal puncture, require discontinuation of apixaban for ≥48 hours in patients with normal renal function 3
Do not use bridging anticoagulation, as it increases bleeding risk without reducing thrombotic events 2, 4
Resume apixaban at least 24-48 hours after the procedure, once adequate hemostasis is confirmed 1, 4

For elderly patients (≥80 years), add an extra 24 hours to the standard interruption period 2
Consider alternative anticoagulation strategies or extended interruption periods in patients with severe renal dysfunction (CrCl <25 mL/min) 1